Peer-reviewedCC BY 4.0Frontiers in Immunology
Editorial: The breast cancer tumor microenvironment: from model systems to clinical translation
4 affiliations
- 1Department of Haematology, School of Medical Sciences, Universiti Sains Malaysia
- 2Department of Biology, Faculty of Education, Omdurman Islamic University
- 3Department of Immunology, School of Medical Sciences, Universiti Sains Malaysia
- 4UPMC Hillman Cancer Center, Division of Malignant Hematology and Medical Oncology, Department of Medicine, University of Pittsburgh School of Medicine
Related
- Tumor microenvironment-driven immune evasion in triple-negative breast cancer: mechanisms, clinical challenges, and therapeutic opportunities
- Editorial: Targeted therapies in gastric cancer: molecular signatures and immune microenvironment insights
- Editorial: Preclinical models and emerging technologies to study the effects of the tumor microenvironment on cancer heterogeneity and drug resistance
- Bioactive peptides in cancer and inflammation: Mechanisms, model systems and clinical translation
- Patient-Derived Organoids as a Model to Understand Tumor Microenvironment-Driven Nano-Bio Interactions - A Framework Towards Improved Nanomedicine Translation
BibTeX
@article{mussa2026editorial,
title = {{Editorial: The breast cancer tumor microenvironment: from model systems to clinical translation}},
author = {Ali Mussa and Rohimah Mohamud and Mohammad AI Al-Hatamleh},
journal = {Frontiers in Immunology},
year = {2026},
month = nov,
doi = {10.3389/fimmu.2026.2025912},
url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.2025912/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Editorial: The breast cancer tumor microenvironment: from model systems to clinical translation
AU - Ali Mussa
AU - Rohimah Mohamud
AU - Mohammad AI Al-Hatamleh
PY - 2026
DA - 2026/11/03
JO - Frontiers in Immunology
DO - 10.3389/fimmu.2026.2025912
UR - https://www.frontiersin.org/articles/10.3389/fimmu.2026.2025912/full
SN - 1664-3224
ER -